Hachenberg T
Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Westfälische Wilhelms-Universität Münster.
Z Kardiol. 1994;83 Suppl 2:63-8.
Ten patients with low cardiac output syndrome (LCOS, cardiac index [CI] = 1.8 +/- 0.24 L.min-1.m-2, pulmonary artery occlusion pressure [PAOP] = 19 +/- 4 mmHg, systolic arterial pressure [APsys] = 76 +/- 5 mmHg) were treated with catecholamines and nitroglycerin. This therapy achieved stable hemodynamic conditions (CI 2.5 +/- 0.2 L.min-1.m-2, PAOP 14 +/- 5 mmHg, APsys = 110 +/- 17 mmHg). Addition of enoximone (bolus dose 1.0 mg.kg-1 followed by continuous infusion of 7 micrograms.kg-1.min-1) induced an increase of CI to 3.6 +/- 1.3 L.min-1.m-2 (p < 0.05) and of left ventricular stroke work index (LVSWI) from 21.8 +/- 3.6 g.m.m-2 to 29.3 +/- 10.1 g.m.m-2 (p < 0.05). Systemic vascular resistance decreased from 1300 +/- 415 dyn.s.cm-5 to 972 +/- 390 dyn.s.cm-5 (p < 0.01). No alterations of heart rate, mean arterial or pulmonary arterial pressure and PAOP were observed. Likewise, enoximone had no effect on gas exchange. Oxygen consumption index (VO2I) was elevated from 83 +/- 22 mL.min-1.m-2 to 126 +/- 31 mL.min-1.m-2 (p < 0.01) and oxygen delivery index (DO2I) increased from 348 +/- 112 mL.min-1.m-2 to 498 +/- 206 mL.min-1.m-2 (p < 0.05). In contrast, oxygen extraction ration remained unchanged (29 +/- 10% n.s.). Oxygen consumption and delivery were significantly lower during treatment of LCOS with catecholamines and nitroglycerin when compared with a matched group of patients without postoperative cardiac failure.(ABSTRACT TRUNCATED AT 250 WORDS)
10例低心排血量综合征(LCOS,心脏指数[CI]=1.8±0.24L·min⁻¹·m⁻²,肺动脉闭塞压[PAOP]=19±4mmHg,收缩动脉压[APsys]=76±5mmHg)患者接受了儿茶酚胺和硝酸甘油治疗。该治疗实现了血流动力学稳定(CI 2.5±0.2L·min⁻¹·m⁻²,PAOP 14±5mmHg,APsys=110±17mmHg)。加用依诺昔酮(静脉推注剂量1.0mg·kg⁻¹,随后持续输注7μg·kg⁻¹·min⁻¹)使CI增加至3.6±1.3L·min⁻¹·m⁻²(p<0.05),左心室每搏功指数(LVSWI)从21.8±3.6g·m·m⁻²增加至29.3±10.1g·m·m⁻²(p<0.05)。全身血管阻力从1300±415dyn·s·cm⁻⁵降至972±390dyn·s·cm⁻⁵(p<0.01)。未观察到心率、平均动脉压或肺动脉压及PAOP的改变。同样,依诺昔酮对气体交换无影响。氧耗指数(VO2I)从83±22mL·min⁻¹·m⁻²升高至126±31mL·min⁻¹·m⁻²(p<0.01),氧输送指数(DO2I)从348±112mL·min⁻¹·m⁻²增加至498±206mL·min⁻¹·m⁻²(p<0.05)。相比之下,氧摄取率保持不变(29±10%,无统计学差异)。与一组无术后心力衰竭的匹配患者相比,在使用儿茶酚胺和硝酸甘油治疗LCOS期间,氧消耗和输送显著降低。(摘要截断于250字)